Gralise

Depomed Inc (NASDAQ: DEPO) shares have surged about 25 percent since mid-February, and UBS’ Ami Fadia believes there is limited upside going forward. Fadia downgraded the rating on the company from Buy to Neutral, with a price target of $20. Limited Upside The analyst believes there could be...

U.S. stocks rose as geopolitical events took a back seat and investors found positives in housing and consumer price index data released Tuesday. The markets followed the lead of Apple which closed at an all-time split-adjusted high of $100.53. Earnings from Home Depot and TJX Companies also...